Use of intramyocardial autologous bone marrow CD133+ cells in ischaemia and refractory angina

Summary

Can injecting bone marrow cells have an effect on myocardial perfusion in patients with refractory angina? Is there any additional benefit over placebo?

Join W. Wojakowski as he introduces the randomised placebo-controlled REGENT-VSEL trial of intramyocardial autologous bone marrow CD133+ cells examining their effect on left ventricle perfusion and function in patients with inducible ischaemia and refractory angina…learn about the fascinating results of this trial here!